BHCFX Mutual Fund

BHCFX Mutual Fund

NAV$22.55

Fund Essentials - as of Mar 31, 2026

Net Assets
-
Expense Ratio
1.10%
Dividend Yield (Current)
-
Holdings
41
Inception Date
Apr 30, 2018
Fund Family
Baron Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Unspecified

Performance

YTD+3.97%
1 Year+23.95%
3 Year+5.42%
5 Year+1.32%

Asset Allocation

Stocks: 100.00%

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly And Company9.95%
AZN:LNAstrazeneca Plc Adr5.09%
JNJJOHNSON AND JOHNSON4.58%
TMOThermo Fisher Scientific Inc4.25%
MTDMettler-Toledo International, Inc.3.99%
Top 10 Concentration: 43.86%Report Date: Mar 31, 2026
Download all 41 holdings for BHCFX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Unspecified
Latest Distribution
$0.22
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
FundXLS Pro
See how BHCFX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
X-ray my whole portfolio$45/quarter Pro · Cancel anytime
From MarketXLS, trusted since 2014.

BHCFX Mutual Fund Overview

BHCFX Mutual Fund (Baron Health Care Fund Retail Class) is managed by Baron Funds. BHCFX expense ratio is 1.10%, holding 41 positions across sectors including Health Care, Real Estate. Inception date: 2018-04-30.

BHCFX performance shows a YTD return of 3.97%. The 1-year return is 23.95% and the 5-year return is 1.32%.

BHCFX top holdings include Eli Lilly And Company (9.9%), Astrazeneca Plc Adr (5.1%), JOHNSON AND JOHNSON (4.6%), Thermo Fisher Scientific Inc (4.3%), Mettler-Toledo International, Inc. (4.0%). Go to all BHCFX holdings, BHCFX sectors, or BHCFX dividends.

BHCFX can be compared against other funds. Use BHCFX overlap to find shared positions, or BHCFX vs another fund for a side-by-side view. BHCFX alternatives are available via the screener, along with tax-loss harvesting opportunities.